Citadel Advisors’s Spartan Acquisition Corp. III Warrants, exercisable for one share of Class A Common Stock SPAQ.WS Stock Holding History

Citadel Advisors’s Portfolio SPAQ.WS Stock Details SPAQ.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-12,960	Closed	-$19K	–	15204
2021 Q4	$19K	Sell	12,960 -171,177	-93%	-$224K	﹤0.01%	13593
2021 Q3	$203K	Buy	184,137 +71,709	+64%	+$83.6K	﹤0.01%	11964
2021 Q2	$134K	Buy	+112,428	New	+$118K	﹤0.01%	12633

Other funds holding SPAQ.WS

PCR

Potrero Capital Research San Francisco, California $163M AUM 79.07% 1-Year Est. Return

Citadel Advisors's SPAQ.WS Position: Q1 2022 in Review

Citadel Advisors sold out of Spartan Acquisition Corp. III Warrants, exercisable for one share of Class A Common Stock (SPAQ.WS) in Q1 2022, closing a stake of 12,960 shares — an estimated $19K sold.

Citadel Advisors first reported a position in SPAQ.WS in Q2 2021 and held it in 3 quarters. The position peaked at $203K in Q3 2021. 1 fund tracked by Wall St. Rank holds SPAQ.WS as of Q1 2022.

Citadel Advisors reported no remaining Spartan Acquisition Corp. III Warrants, exercisable for one share of Class A Common Stock position as of Q1 2022 after selling out during the quarter.
Citadel Advisors sold 12,960 Spartan Acquisition Corp. III Warrants, exercisable for one share of Class A Common Stock shares in Q1 2022, an estimated $19K.
Citadel Advisors first reported a position in Spartan Acquisition Corp. III Warrants, exercisable for one share of Class A Common Stock in Q2 2021 and held it in 3 quarters.
Citadel Advisors's Spartan Acquisition Corp. III Warrants, exercisable for one share of Class A Common Stock position peaked at $203K in Q3 2021.
1 fund tracked by Wall St. Rank held Spartan Acquisition Corp. III Warrants, exercisable for one share of Class A Common Stock as of Q1 2022.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.